Abstract:Background: One of the most common and efficient methods for detecting mutations in genes is PCR amplification followed by direct sequencing. Until recently, the process of designing PCR assays has been to focus on individual assay parameters rather than concentrating on matching conditions for a set of assays. Primers for each individual assay were selected based on location and sequence concerns. The two primer sequences were then iteratively adjusted to make the individual assays work properly. This generally resulted in groups of assays with different annealing temperatures that required the use of multiple thermal cyclers or multiple passes in a single thermal cycler making diagnostic testing time-consuming, laborious and expensive.These factors have severely hampered diagnostic testing services, leaving many families without an answer for the exact cause of a familial genetic disease. A search of GeneTests for sequencing analysis of the entire coding sequence for genes that are known to cause muscular dystrophies returns only a small list of laboratories that perform comprehensive gene panels.The hypothesis for the study was that a complete set of universal assays can be designed to amplify and sequence any gene or family of genes using computer aided design tools. If true, this would allow automation and optimization of the mutation detection process resulting in reduced cost and increased throughput.Results: An automated process has been developed for the detection of deletions, duplications/insertions and point mutations in any gene or family of genes and has been applied to ten genes known to bear mutations that cause muscular dystrophy: DMD; CAV3; CAPN3; FKRP; TRIM32; LMNA; SGCA; SGCB; SGCG; SGCD. Using this process, mutations have been found in five DMD patients and four LGMD patients (one in the FKRP gene, one in the CAV3 gene, and two likely causative heterozygous pairs of variations in the CAPN3 gene of two other patients). Methods and assay sequences are reported in this paper.Conclusion: This automated process allows laboratories to discover DNA variations in a short time and at low cost.

Deep Mutational Scanning in Disease-related Genes with Saturation Mutagenesis-Reinforced Functional Assays (SMuRF)

Saturation mutagenesis-reinforced functional assays for disease-related genes

Germline Saturation Mutagenesis Induces Skeletal Phenotypes in Mice

Variant-aware Saturating Mutagenesis Using Multiple Cas9 Nucleases Identifies Regulatory Elements at Trait-Associated Loci

Automated DNA Mutation Detection Using Universal Conditions Direct Sequencing: Application to Ten Muscular Dystrophy Genes

Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations

Sequence-Based Prioritization of Nonsynonymous Single-Nucleotide Polymorphisms for the Study of Disease Mutations

Multimodal scanning of genetic variants with base and prime editing

Functional Assays to Screen and Dissect Genomic Hits: Doubling Down on the National Investment in Genomic Research

Deep Mutational Scan of an SCN5A Voltage Sensor

CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency

Functional phenotyping of genomic variants using multiomic scDNA-scRNA-seq

RNA variant assessment using transactivation and transdifferentiation

Prediction of Functional Regulatory SNPs in Monogenic and Complex Disease.

Saturation profiling of drug-resistant genetic variants using prime editing

Saturation genome editing maps the functional spectrum of pathogenic VHL alleles

Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease

MmisAT and MmisP: an efficient and accurate suite of variant analysis toolkit for primary mitochondrial diseases

Saturation Mutagenesis Defines Novel Mouse Models of Severe Spine Deformity.

A Machine Learning Enhanced EMS Mutagenesis Probability Map for Efficient Identification of Causal Mutations in

Development and Validation of a One-Step SMN Assay for Genetic Testing in Spinal Muscular Atrophy Via MALDI-TOF MS